نتائج البحث 131-140 من 2257 لعملية البحث عن anti-TNF drugs
Gender-affirming hormone therapy (adult). Mayo Clinic; 2022. Nippoldt TB (expert opinion). Mayo Clinic. Feb. 7, 2024. ذات صلة. اضطراب الهُوِية الجنسية ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
However, the use of anti-inflammatory agents in the prevention of colorectal cancer is controversial, although there is some suggestion that its use may ...
Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...
Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.
... treatment for patients with solid tumors or non-Hodgkin lymphomas. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy ...
The purpose of this study is to gain a better understanding of the treatment and significant morbidity associated with sinonasal cancer and identify the impact ...
This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...
This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy ... therapy treatment in patients with low gene risk score.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.